BNF:

Not listed

Status:

Red

Decision Date:

December 2016

Comments

RED: For the treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).

NHS England drug. To be used in line with NHS England commissioning intentions

Red Drug Classifications

• 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists

search again